Irish Life Investment Managers’s Myriad Genetics MYGN Stock Holding History

Irish Life Investment Managers’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$122K	Buy	+4,560	New	+$132K	﹤0.01%	850

Other funds holding MYGN

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Irish Life Investment Managers's MYGN Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Myriad Genetics (MYGN) in Q2 2013: 4,560 shares worth $122K. The stake represents ﹤0.01% of the portfolio and ranks #850 among its holdings.

261 funds tracked by Wall St. Rank hold MYGN as of Q2 2013.

Irish Life Investment Managers held 4,560 shares of Myriad Genetics worth $122K as of Q2 2013.
Myriad Genetics was a new Irish Life Investment Managers position in Q2 2013.
Myriad Genetics made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #850 holding.
261 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.